Atorvastatin Calcium
Product Images NDC 68071-2585

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-2585). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2585 9)

Label for Atorvastatin Calcium 40 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a package of 90 tablets, prescription only (Rx Only). It includes NDC 68071-2585-9 and storage instructions to keep at controlled temperature 68-77°F. The label also has warnings to keep out of reach of children and advises consulting a doctor for side effects.*

FDA Label Image

Figure-01 (Figure 01)

A line graph showing the cumulative incidence percentage over a period of 3.5 years comparing Atorvastatin with Placebo. The graph includes two lines: a solid line for Atorvastatin with lower cumulative incidence and a dashed line for Placebo with higher incidence. Hazard ratio and p-value are noted in the graph area.*

FDA Label Image

Figure-02 (Figure 02)

A line graph comparing cumulative hazard percentages over time between Atorvastatin and placebo groups during a four-year follow-up period. The x-axis represents years to first primary endpoint up to four years, while the y-axis shows cumulative hazard percentage. The graph includes hazard ratio and p-value indicating statistical analysis results.*

FDA Label Image

Figure-03 (Figure 03)

A line graph depicting the time to first major cardiovascular endpoint over a 5-year period comparing Atorvastatin 10 mg and Atorvastatin 80 mg. The y-axis represents the percentage of subjects experiencing the event, and the x-axis shows time in years. The graph indicates event rates for both dosages with a hazard ratio (HR) of 0.78 and a p-value of 0.0002, suggesting a comparison of cardiovascular outcomes between the two doses.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure diagram of atorvastatin calcium, displaying the molecular arrangement including calcium ions, labeled as part of the active ingredient atorvastatin calcium.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.